Combined General and Spinal Anesthesia vs. Combined General and Spinal Anesthesia With Neuromuscular Blockade for Operative Repair of Hip Fractures
Phase of Trial: Phase IV
Latest Information Update: 22 Aug 2018
At a glance
- Drugs Rocuronium bromide (Primary) ; Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 13 Aug 2018 Planned End Date changed from 30 Jul 2018 to 1 Aug 2020.
- 13 Aug 2018 Planned primary completion date changed from 30 Jul 2018 to 1 Aug 2019.
- 24 Jul 2017 New trial record